Coronary artery lesions in patients with SARS-CoV-2 infection more likely to become high-risk plaques. HealthDay News — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is ...

Bonus Biogroup has received FDA approval for an IND application to conduct a Phase III clinical trial of a drug designed to treat acute respiratory distress syndrome (ARDS), especially in severe COVID ...

Seven rheumatology researchers have authored a paper questioning the utility of the 2024 National Academies’ broad definition of long COVID.

On this day in 2020, the World Health Organization (WHO) named a disease spreading from Wuhan, China, COVID-19. On Feb. 11, ...

Guillain-Barré Syndrome ... Acute Motor Axonal Neuropathy (AMAN): Common in Asia and Central/South America, primarily affects motor nerves. Acute Motor-Sensory Axonal Neuropathy (AMSAN): A severe ...

Since then, Lenhart has remained on a ventilator. She has also developed Acute Respiratory Distress Syndrome. According to the fundraiser, blood transfusions have helped keep Lenhart stable while in ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

Further, it was stated that the committee cited the following reasons for the death: Immediate cause of death: Severe acute respiratory distress syndrome, Antecedent cause of death: Bilateral ...